Notable Analyst Rating Changes 04/01: (HBAN) (LVS) (AGN) Upgraded; (BIDU) (IPG) (GHL) Downgraded

April 1, 2011 11:01 AM EDT Send to a Friend
UPGRADES
Jefferies lifts Huntington Bancshares (Nasdaq: HBAN) from Hold to Buy, with an $8 price target. Click Here for more color.

Credit Suisse raises Las Vegas Sands (NYSE: LVS) from Hold to Buy, with a fresh $55 price target. Click Here for more color.

Leerink Swann upgraded Allergen (NYSE: AGN) from Market Perform to Outperform, with a valuation range of $82 - $83. Click Here for more color.

JPMorgan upgrades US Airways (NYSE: LCC) from Neutral to Overweight, retaining a $12 price target.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES
Mizuho Securities lowers Baidu (Nasdaq: BIDU) from Buy to Neutral.

Nomura Securities downgrades Interpublic Group (NYSE: IPG) from Buy to Neutral, with a price target of $13.50. Click Here for more color.

Goldman Sachs reduces Greenhill (NYSE: GHL) from Neutral to Sell and lowered its price target from $80 to $65. Click Here for more color.

Nomura Securities cuts Nokia (NYSE: NOK) from Neutral to Reduce.

For daily real-time Downgrades go to http://www.streetinsider.com/downgrades

NEW COVERAGE
Madison Williams starts Schlumberger (NYSE: SLB) with a Buy, and price target of $115.

Deutsche Bank initiates Huntington Ingalls (NYSE: HII) with a Hold rating and $40 price target. Click Here for more color.

Cowen starts Threshold Pharmaceuticals (Nasdaq: THLD) with an Outperform, and $12 price target.

Nomura Securities assumes coverage on Omnicom Group (NYSE: OMC) with a Neutral, dropped from $57 to $51.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Credit Suisse, Deutsche Bank, JPMorgan, Jefferies & Co, Nomura, Notable Analyst Rating Changes, Cowen & Co, Earnings

Add Your Comment